Malignant Neoplasms in Patients Undergoing FDG-PET/CT
Conditions
Interventions
Control group: Water vapor is intermittently diffused for 30 minutes using a nebulizing diffuser to reproduce an environment without aroma stimulation.
Japanese essential oils (Citrus unshiu and yuzu)
Sponsors
Asahikawa Medical Univerity
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients scheduled to undergo FDG-PET/CT for cancer diagnosis at Asahikawa Medical University Hospital Aged 20 years or older and capable of providing informed consent No diagnosis of severe cognitive impairment Judged to be in a stable physical and mental condition and able to undergo the study procedures No known hypersensitivity or allergy to aromatic components Provided written informed consent for participation in the study
Exclusion criteria
Exclusion criteria: History of fragrance hypersensitivity, asthma, or severe anxiety disorders that may cause adverse reactions to aroma stimulation Use of medications affecting heart rate variability (e.g.,beta blockers or antiarrhythmic drugs) or use of cardiac devices such as pacemakers Presence of psychiatric disorders or dementia that makes it difficult to appropriately respond to questionnaires
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in State-Trait Anxiety Inventory-State (STAI-S) scores measured at baseline, immediately before the examination, and after the examination. | — |
Countries
Japan
Contacts
Public ContactMichihiro Nakayama
Asahikawa Medical University Department of Radiology
Outcome results
None listed